The Burden of Cardiovascular Risk in Chronic Kidney Disease and Dialysis Patients (Cardiorenal Syndrome Type 4)

被引：0

作者：

House, Andrew A. ^{[1
]}

Ronco, Claudio ^{[2
]}

机构：

[1] Univ Western Ontario, Univ Hosp, London Hlth Sci Ctr, Schulich Sch Med & Dent,Div Nephrol, London, ON N6A 5A5, Canada

[2] San Bortolo Hosp, Dept Nephrol Dialysis & Transplantat, Int Renal Res Inst IRRIV, Vicenza, Italy

来源：

HEMODIALYSIS: NEW METHODS AND FUTURE TECHNOLOGY | 2011年 / 171卷

关键词：

SYNDROMES WORKGROUP STATEMENTS; SUDDEN CARDIAC DEATH; MORTALITY RISK; HEART-FAILURE; EPIDEMIOLOGY; ASSOCIATION; PREVALENCE; SURVIVAL;

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Type 4 cardiorenal syndrome is a growing societal problem as the aging population, with increasing incidence of chronic kidney disease (CKD), diabetes, obesity, hypertension, and other cardiovascular risks, leads to higher numbers of individuals suffering the complications of this bidirectional disorder. In this review, the immense burden of cardiovascular risk faced by patients on dialysis, as well as lesser degrees of CKD, will be examined, with emphasis on rates of acute coronary syndrome/coronary insufficiency, congestive heart failure/left ventricular hypertrophy, and cardiac arrhythmia/sudden cardiac death. Copyright (C) 2011 S. Karger AG, Basel

引用

页码：50 / 56

页数：7

共 50 条

[31] Chronic kidney disease and cognitive decline in patients with type 2 diabetes at elevated cardiovascular risk
Verhagen, Chloe
Janssen, Jolien
Minderhoud, Crista A.
van den Berg, Esther
Wanner, Christoph
Passera, Anna
Johansen, Odd Erik
Biessels, Geert Jan
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2022, 36 (10)
[32] Treating chronic kidney disease to reduce cardiovascular risk
Cice, Gennaro
Monzo, Luca
Calo, Leonardo
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2023, 25 (SUPPB) : B50 - B54
[33] Obstructive sleep apnea in non-dialysis chronic kidney disease patients
Shanmugam, G. Vijay
Abraham, Georgi
Mathew, Milly
Ilangovan, V.
Mohapatra, Madhusmita
Singh, Tripat
RENAL FAILURE, 2015, 37 (02) : 214 - 218
[34] Assessment of treatment burden and its impact on quality of life in dialysis-dependent and pre-dialysis chronic kidney disease patients
Al-mansouri, Asmaa
Al-Ali, Fadwa Saqr
Hamad, Abdullah Ibrahim
Ibrahim, Mohamed Izham Mohamed
Kheir, Nadir
Ibrahim, Rania Abdelaziz
AlBakri, Muna
Awaisu, Ahmed
RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2021, 17 (11) : 1937 - 1944
[35] The Acute Cardiorenal Syndrome: Burden and Mechanisms of Disease
Nijst P.
Mullens W.
Current Heart Failure Reports, 2014, 11 (4) : 453 - 462
[36] Recent Advances in Understanding of Cardiovascular Diseases in Patients with Chronic Kidney Disease
Krisanapan, Pajaree
Pattharanitima, Pattharawin
Thongprayoon, Charat
Cheungpasitporn, Wisit
JOURNAL OF CLINICAL MEDICINE, 2022, 11 (16)
[37] Type 4 cardiorenal syndrome
Pinheiro da Silva, Ana Luisa
Vaz da Silva, Manuel Joaquim
REVISTA PORTUGUESA DE CARDIOLOGIA, 2016, 35 (11) : 601 - 616
[38] Treatment motivation in patients with chronic cardiorenal syndrome
Efremova, E. V.
Shutov, A. M.
Borodulina, E. O.
TERAPEVTICHESKII ARKHIV, 2015, 87 (12) : 13 - 17
[39] Race, Biomarkers, and Cardiovascular Disease in Patients With Chronic Kidney Disease
Nicholas, Susanne B.
Norris, Keith C.
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (18):
[40] Chronic kidney disease in Spain: Prevalence and impact of accumulation of cardiovascular risk factorsN
Gorostidi, Manuel
Sanchez-Martinez, Mercedes
Ruilope, Luis M.
Graciani, Auxiliadora
de la Cruz, Juan J.
Santamaria, Rafael
del Pino, Maria D.
Guallar-Castillon, Pilar
de Alvaro, Fernando
Rodriguez-Artalejo, Fernando
Banegas, Jose R.
NEFROLOGIA, 2018, 38 (06): : 606 - 615

← 1 2 3 4 5 →